Finder makes money from featured partners, but editorial opinions are our own.

How to invest in the Dragonfly Biosciences IPO

Dragonfly Biosciences is set to go public, here's what you need to know if you're looking to buy in.

What we know so far

Offer price: $0.20
Proposed code: DRF
Expected raise: $3,000,000 – $5,000,000
Expected listing: TBA
Compare trading platforms

Organic CBD production company Dragonfly Biosciences is set to list on the Australian Securities Exchange (ASX). This means you'll soon be able to buy company shares through a broker. Here's what we know about the initial public offering (IPO), including how to invest before it lists and how to buy in when it lists.

Where to invest in the Dragonfly Biosciences IPO

You can invest in pre-IPO stock through a participating broker or lead manager before the offer closes on 4 May 2023. In this case, the Dragonfly Biosciences IPO is being lead managed by Finexia Securities Limited and Lazarus Corporate Finance Pty Ltd.

If you're already registered with a broker, check if they're offering pre-listed stock or think about signing up to a participating broker.

However, it can be tricky for regular investors to participate in IPOs because only a few firms are usually allocated pre-IPO stock. In most cases, these are full-service brokers that require a large initial deposit.

Your other easier option is to buy shares in Dragonfly Biosciences once it goes public. You can do that through a share trading platform:

How to buy shares when Dragonfly Biosciences lists

  1. Compare share trading platforms. To buy shares in an Australian-listed company, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
  3. Search for Dragonfly Biosciences. Find the share by name or ticker symbol: DRF. You can also search for any other shares traded publicly on exchanges available within your chosen platform.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Dragonfly Biosciences reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At price of at you're buying the shares, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
  6. Check in on your investment. Congratulations, you own a part of Dragonfly Biosciences. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

What we know about the Dragonfly Biosciences IPO

Dragonfly Biosciences lodged its prospectus with the Australian Securities and Investments Commission (ASIC) to list on the ASX under the ticker symbol DRF.

Finexia Securities Limited and Lazarus Corporate Finance Pty Ltd were appointed as lead managers with an expected raise of $3,000,000 – $5,000,000 at $0.20 per share. You can check out some of the key dates and figures in the table below:


Dragonfly Biosciences IPO key numbers
Offer price $0.20
Dividend yield 0%
Total number of shares available under the offer 15,000,000 – 25,000,000
Proposed ASX code ASX: DRF
Target market cap $30,190,914 – $32,190,914
Retail offer opens 20 April 2023
Retail offer closes 4 May 2023
Expected listing on ASX TBA
Expected dispatch of holding statements 8 May 2023
Source: Dragonfly Biosciences prospectus

According to latest information available, retail investors (regular investors) have between 20 April 2023 and 4 May 2023 to participate in the Dragonfly Biosciences IPO. After the retail offer close date, you'll need to wait until the stock is publicly available on the ASX to buy shares.

Compare share trading platforms

The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.
1 - 6 of 6
Updated regularly
Name Product Standard brokerage fee Inactivity fee Asset class
eToro
Finder AwardExclusive
eToro
$0
US$10 per month if there’s been no log-in for 12 months
ASX shares, Global shares, US shares, ETFs
CFD service. Capital at risk.
Finder exclusive: Get 12 months of investment tracking app Delta PRO for free when you fund your eToro account (T&Cs apply).
Join the world’s biggest social trading network when you trade stocks, commodities and currencies from the one account.
Go to site
More Info
IG Share Trading
Finder Award
IG Share Trading
$8
$0
ASX shares, Global shares, US shares, UK shares, ETFs
$0 brokerage for US and global shares plus get an active trader discount of $5 commission on Australian shares.
Enjoy some of the lowest brokerage fees on the market when trading Australian and international shares, plus get access to 24-hour customer support.
Go to site
More Info
Moomoo Share Trading
Exclusive
Moomoo Share Trading
$8.80
$0
ASX shares, Global shares, US shares, ETFs
Finder exclusive: Get an additional 30 days on top of the regular brokerage-free period for new accounts (see link for details). T&Cs apply.
Trade shares on the ASX, the US markets and buy ETFs with Moomoo. Plus join a community over 18 million investors.
Go to site
More Info
CMC Markets Invest
Finder Award
CMC Markets Invest
$0
$0
ASX shares, Global shares, Options trading, US shares, mFunds, ETFs
Special offer: Transfer your international stocks to CMC Invest and receive $100 credit on your trading account until Nov 30, 2023 (T&Cs apply).
Trade up to 35,000 products, including shares, ETFs and managed funds, plus access up to 15 major global and Australian stock exchanges. Plus, buy Aussie shares for $0 brokerage up to $1,000. (Limited to one buy order per stock per trading day).
Go to site
More Info
Webull
Webull
$4.90
$0
ASX shares, Options trading, US shares, ETFs
Fund your new account with $500 and place 1 trade to get $100 in free rewards until November 30, 2023. Plus, earn up to 5.2% p.a. interest on your US cash account (T&Cs apply).
Trade ASX and US stocks and US options, plus gain access to inbuilt news platforms and educational resources. You can also start trading for less with fractional shares.
Go to site
More Info
Tiger Brokers
Exclusive
Tiger Brokers
$5.50
$0
ASX shares, Global shares, US shares, ETFs
Finder exclusive: Get 15 commission-free trades on US or ASX equities for the first 180 days plus US$50 fractional shares when you deposit at least $500 within the first 7 days of account opening. Plus, all new customers get 1 free trade per month for the first 12 months (T&Cs apply).
Get one brokerage-free trade per month for the first 12 months for US or ASX markets. T&Cs apply.
Go to site
More Info
loading

Balance sheet

In Q2FY23, the company generated $802,000 of revenue. Estimated net profit (NPAT) in Q2FY23 was -$1,193,000, and -$12,627,000 in the prior year.

Company history

Dragonfly Biosciences launched in 2017 by Ben Langley and is headquartered in Sydney, NSW 2000.

How do I buy shares?

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades. Read the Product Disclosure Statement (PDS) and Target Market Determination (TMD) for the product on the provider's website.

More guides on Finder

Ask an Expert

You are about to post a question on finder.com.au:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com.au is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder only provides general advice and factual information, so consider your own circumstances, or seek advice before you decide to act on our content. By submitting a question, you're accepting our Terms of Use, Disclaimer & Privacy Policy and 6. Finder Group Privacy & Cookies Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site